ACOR
ACOR Real Time Price USDRecent trades of ACOR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ACOR's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$7,500 May 01, 2017 Issue: None
-
$22,500 Apr 18, 2017 Issue: Budget/Appropriations
-
$22,500 Jan 10, 2017 Issue: Budget/Appropriations
-
$22,500 Oct 07, 2016 Issue: Budget/Appropriations
-
$22,500 Jun 29, 2016 Issue: Budget/Appropriations
-
$22,500 Apr 19, 2016 Issue: Budget/Appropriations
-
$22,500 Jan 15, 2016 Issue: Budget/Appropriations
-
$22,500 Oct 14, 2015 Issue: Budget/Appropriations
-
$22,500 Jul 01, 2015 Issue: Budget/Appropriations
-
$30,000 Jan 23, 2014 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$30,000 Oct 21, 2013 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
-
$50,000 Oct 21, 2013 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$30,000 Oct 21, 2013 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$50,000 Jan 22, 2013 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$50,000 Oct 19, 2012 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$50,000 Jul 17, 2012 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
-
$60,000 Apr 20, 2012 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$60,000 Jan 18, 2012 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$50,000 Oct 20, 2011 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$50,000 Jul 20, 2011 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
-
$50,000 Apr 20, 2011 Issue: Budget/Appropriations Health Issues Science/Technology
-
$30,000 Jan 20, 2011 Issue: Health Issues Budget/Appropriations Pharmacy
-
$60,000 Oct 20, 2010 Issue: Health Issues Budget/Appropriations Pharmacy
-
$60,000 Jul 20, 2010 Issue: Budget/Appropriations Health Issues Pharmacy
-
$60,000 Apr 20, 2010 Issue: Health Issues Pharmacy Budget/Appropriations
-
$60,000 Jan 20, 2010 Issue: Pharmacy Budget/Appropriations Health Issues
-
$60,000 Oct 15, 2009 Issue: Health Issues Budget/Appropriations Pharmacy
-
$60,000 Jul 17, 2009 Issue: Pharmacy Health Issues Budget/Appropriations
-
$60,000 Apr 17, 2009 Issue: Health Issues Budget/Appropriations Pharmacy
-
$60,000 Jan 16, 2009 Issue: Pharmacy Health Issues Budget/Appropriations
-
$60,000 Oct 16, 2008 Issue: Budget/Appropriations Health Issues Pharmacy
-
$60,000 Jul 21, 2008 Issue: Health Issues Budget/Appropriations Pharmacy
Estimated quarterly lobbying spending
ACOR Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
- $0 2024-01-17 00:00:00 Agency: Department of Veterans Affairs
- $444,505 2023-10-31 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-09-08 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-01-26 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $529,877 2022-12-19 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $158,963 2022-09-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $105,975 2022-03-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $68,268 2021-11-02 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $68,268 2021-09-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $59,734 2021-06-07 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $102,401 2021-03-25 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $51,201 2021-01-27 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Recent insights relating to ACOR
Recent picks made for ACOR stock on CNBC
ETFs with the largest estimated holdings in ACOR
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ACOR stock a Buy, Sell, or Hold?
- What is the price target for $ACOR stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ACOR stock?
- Who owns the most shares of $ACOR stock?
- What funds own $ACOR stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ACOR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.